New Shares from AIXTRON Stock Option Program will be Traded under Separate ISIN

AIXTRON SE worldwide leading provider of deposition equipment to the semiconductor industry, has a number of stock option programs in place that grant the members of the Executive Board and employees the right to purchase AIXTRON shares under certain conditions.

Under the terms of the stock option plan 2007, stock options can currently be exercised. New shares resulting from exercised options are not entitled for dividend for fiscal year 2010 and will therefore be traded on the Frankfurt Stock Exchange under the separate ISIN DE000A1H30A0 until and including the day of the AGM 2011 on May 19, 2011.
 

Disclaimers of Warranties
1. The website does not warrant the following:
1.1 The services from the website meets your requirement;
1.2 The accuracy, completeness, or timeliness of the service;
1.3 The accuracy, reliability of conclusions drawn from using the service;
1.4 The accuracy, completeness, or timeliness, or security of any information that you download from the website
2. The services provided by the website is intended for your reference only. The website shall be not be responsible for investment decisions, damages, or other losses resulting from use of the website or the information contained therein<
Proprietary Rights
You may not reproduce, modify, create derivative works from, display, perform, publish, distribute, disseminate, broadcast or circulate to any third party, any materials contained on the services without the express prior written consent of the website or its legal owner.

Today, the deep integration of “AI+LED” has become a key strategic focus for enterprises racing to establish their positions: from image quality enhancement to energy efficiency management, from intelligent interaction to content g... READ MORE

  Samsung Electronics America and Care New England today announced the newly expanded Labor and Delivery Center at Women & Infants Hospital in Providence, R. I., with a comprehensive display ecosystem that enhances patient experiences... READ MORE